Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Post (Tweet)
Charles C. C. Owen, Jr., MD, MBA (he/him/his)
Eli Lilly and Company
Poster(s):
P2669 - Effects of Mirikizumab versus Placebo on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized, Controlled Phase 3 Trial of Participants With Crohn’s Disease
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
P2670 - Effects of Mirikizumab and Ustekinumab on Histologic Inflammation Evaluated by Comprehensive Assessment in 5 Intestinal Segments in a Randomized Controlled Phase 3 Trial of Participants With Crohn’s Disease
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET